Cure for cancer worth $50 trillion ( A new study to be published in a forth...)

Cure for cancer worth $50 trillion

A new study, to be published in a forthcoming issue of the Journal of Political Economy, calculates the prospective gains that could be obtained from further progress against major diseases. Kevin M. Murphy and Robert H. Topel, two University of Chicago researchers, estimate that even modest advancements against major diseases would have a significant impact ?a 1 percent reduction in mortality from cancer has a value to Americans of nearly $500 billion. A cure for cancer would be worth about $50 trillion.

"We distinguish two types of health improvements ?those that extend life and those that raise the quality of life," explain the authors. "As the population grows, as incomes grow, and as the baby-boom generation approaches the primary ages of disease-related death, the social value of improvements in health will continue to rise."

Many critiques of rising medical expenditures focus on life-extending procedures for persons near death. By breaking down net gains by age and gender, Murphy and Topel show that the value of increased longevity far exceeds rising medical expenditures overall. Gains in life expectancy over the last century were worth about $1.2 million per person to the current population, with the largest gains at birth and young age.

"An analysis of the value of health improvements is a first step toward evaluating the social returns to medical research and health-augmenting innovations," write the authors. "Improvements in life expectancy raise willingness to pay for further health improvements by increasing the value of remaining life."

Murphy and Topel also chart individual values resulting from the permanent reduction in mortality in several major diseases ?including heart disease, cancer, and diabetes. Overall, reductions in mortality from 1970 to 2000 had an economic value to the U.S. population of $3.2 trillion per year.

Source:University of Chicago Press Journals

Page: 1
Related biology news :

1. Viral DNA sequence a possible trigger for breast cancer
2. Enzyme, lost in most mammals, is shown to protect against UV-induced skin cancer
3. Its not all genetic: Common epigenetic problem doubles cancer risk in mice
4. Columbia research lifts major hurdle to gene therapy for cancer
5. Combination therapy boosts effectiveness of telomere-directed cancer cell death
6. Mitochondrial DNA mutations play significant role in prostate cancer
7. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
8. BRCA1 causes ovarian cancer through indirect, biochemical route
9. Researchers identify target for cancer drugs
10. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
11. First atlas of key brain genes could speed research on cancer, neurological diseases

Post Your Comments:

(Date:12/15/2009)... a standard laboratory model organism, but there are ... analyze blood and blood-forming tissues in this species. ... easy-to-use laboratory resources from Cold Spring Harbor Laboratory ... features step-by-step protocols for the preparation, enumeration, ... and other hematopoietic tissues in the mouse. ...

(Date:12/14/2009)... promoted as a clean-burning, renewable fuel that could help ... problems caused by ozone, compared with gasoline, especially in ... researchers. , Ozone production from both gasoline and ... 85 percent ethanol, is greater in warm sunny weather ... winter, because heat and sunlight contribute to ozone formation. ...

(Date:12/14/2009)... (INTA-CSIC) has shown that hydrogen cyanide, urea and other ... basic biological molecules can be obtained from the salt ... published in the journal Chemistry & Biodiversity , ... Earth. , "We have shown that when Prussian blue ... a substance that could have played a fundamental role ...

Breaking Biology News(10 mins):New source of classical techniques for blood-based studies in the laboratory mouse 2 Ethanol-powered vehicles generate more ozone than gas-powered ones 2 Ethanol-powered vehicles generate more ozone than gas-powered ones 3 Prussian blue linked to the origin of life 2 University Medical Center Mainz Completes Installation of Masimo Noninvasive and Continuous Hemoglobin Throughout Their Operating Rooms Intensive Car 58032 1 University Medical Center Mainz Completes Installation of Masimo Noninvasive and Continuous Hemoglobin Throughout Their Operating Rooms Intensive Car 58032 2 University Medical Center Mainz Completes Installation of Masimo Noninvasive and Continuous Hemoglobin Throughout Their Operating Rooms Intensive Car 58032 3 University Medical Center Mainz Completes Installation of Masimo Noninvasive and Continuous Hemoglobin Throughout Their Operating Rooms Intensive Car 58032 4 University Medical Center Mainz Completes Installation of Masimo Noninvasive and Continuous Hemoglobin Throughout Their Operating Rooms Intensive Car 58032 5 Media small businesses invited to ACS webinar on green chemistry project financing 58027 1 K State geographer working to clarify what sustainability really means to rural decision makers 10035 1 K State geographer working to clarify what sustainability really means to rural decision makers 10035 2

[0] New source of classical techniques for blood-based studies in the laboratory mouse [0] Ethanol-powered vehicles generate more ozone than gas-powered ones [0] Prussian blue linked to the origin of life

... October 9, 2007 MIT Holding, Inc. (OTCBB: MITD), ... successfully tested prototype designs of the patent pending PROVECTOR. ... development of pathogens and parasites found in mosquitoes that ... West Nile virus. The PROVECTOR will initially be made ...

... rats with portal hypertension, ultraClow-dose aspirin has shown a ... Further, this effect is mediated by Cyclooxygenase 2 inhibition. ... team led by Professor C. Doutremepuich, is described in ... 14 issue of the World Journal of Gastroenterology. , ...

... Professor Sir Martin Evans, Professor of Mammalian Genetics at ... 2007 Nobel Prize for Medicine. , The Nobel Assembly ... Professor Sir Martin was one of three winners for ... and DNA recombination in mammals. , Professor Sir Martin ...

Other Biology News:MIT Holding, Georgia Southern University, and MEVLABS successfully test the PROVECTOR 2 Ultra-low-dose aspirin might decrease bleeding severity in portal hypertension 2 Professor Sir Martin Evans wins Nobel Prize for Medicine 2

MIT Holding, Georgia Southern University, and MEVLABS successfully test the PROVECTOR Ultra-low-dose aspirin might decrease bleeding severity in portal hypertension Professor Sir Martin Evans wins Nobel Prize for Medicine

(Date:12/15/2009)... --The Mosaic Company (NYSE: MOS ) plans ... results and financial tables on Tuesday, January 5, 2010, ... Stock Exchange. Results will be available on Mosaic,s ... host a conference call with presentation slides on Wednesday, ... call will begin at 11:00 a.m. Eastern Standard Time ...

(Date:12/15/2009)... The Center for Business Intelligence ... pleased to announce the full agenda for ... Reporting Congress . The forum will take ... 16-17, 2010. ,, Over 1,500 senior-level Finance, ... this premier event since its inception, and ...

(Date:12/15/2009)... and LONDON, Dec. 15 ... Thomson Pharma ® has become the first drug ... protocol and outcome information. This highly anticipated new ... customers this month. ,, Thomson ... intelligence from registries, publications, press releases, conferences, and ...

(Date:12/15/2009)... Office has announced the launch of several innovative new ... services in the current economic climate. The first ... to finance legal services over a period of 6, ... in their start-up companies. The second is aimed ... payment arrangements over 6 to 12 month period at ...

Breaking Biology Technology:Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call 2 CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress 2 Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2 The Prinz Law Office Launches Innovative New Programs to Aid Cash-Strapped Entrepreneurs and Businesses 2

[0] Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call [0] CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress [0] Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials [0] The Prinz Law Office Launches Innovative New Programs to Aid Cash-Strapped Entrepreneurs and Businesses

... Ala., Oct. 31 BioCryst,Pharmaceuticals, Inc. (Nasdaq: ... ended September 30, 2008., Third Quarter 2008 ... September 30, 2008, the Company reported,collaborative and other ... $20.5 million for the three months ended September ...

... Full-Year 2008, PLYMOUTH, Minn., Oct. 31 ev3 ... financial,results for its fiscal third quarter of 2008 and ... were $107.0 million in the third quarter of 2008,representing ... prior year,primarily due to the acquisition of FoxHollow. Third ...

... Va. -- Wind, water, and waves erode billions of ... result, many rivers are plagued with excessive amounts of ... such eroded sediment is the largest nonpoint source pollution ... soil erosion may seem obvious wind, water and wave ...

BioCryst Reports Third Quarter 2008 Financial Results and Provides Corporate Update ev3 Inc. Reports Third Quarter 2008 Financial Results Virginia Tech engineers identify conditions that initiate erosion

... Panels were designed for full-length gene cloning ... to identify the desired cDNA clone. The ... 96-well "Master Plate," where each well contains ... the positive well(s) by gel electrophoresis of ...

... calibrating single-channel and multi-channel pipettes. ,Thanks to ... case, the MCP1-S is ideal for calibrating ... at the users premises. The unit is ... channels are tested automatically. Multi-channel pipettes can ...

... HVJ (hemagglutinating virus of Japan, also ... a tool for transfection of molecules by ... are for siRNA (RNAi), Protein, Oligo, cDNA, ... and in vivo. GenomONE-Neo EX has a ...

Biology Products:

Rapid-Screen Arrayed cDNA Library Panels Master Plates -Mouse Testis from OriGene Technologies Rapid-Screen Arrayed cDNA Library Panels Master Plates -Human Placenta from OriGene Technologies MCP1-S Pipette Calibration Workstation from Mettler Toledo, Inc.GenomONE-Neo EX HVJ-E 4 vial(s) Transfection Reagents from Cosmo Bio Co., Ltd.

( A new study to be published in a forth...)Cure for cancer worth $50 trillion